Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?
Recently, clinical trial data showed that rapid attainment of goal blood pressure (BP) reduces the risk for cardiovascular disease (CVD) events. It is unknown whether patient characteristics linked to the magnitude of CVD risk influence the speed of BP control. Time to attain goal systolic BP (SBP) in Kaplan-Meier survival curves was contrasted for strata of baseline characteristics and intensity of hypertension treatment. Survival analyses showed that albuminuria, diabetes, increased body mass index, millimeters of mercury above Joint National Committee (JNC) SBP goal, higher Framingham risk score, older age, depressed estimated glomerular filtration rate, and greater intensity of antihypertensive drug treatment all predicted slower JNC SBP goal attainment (P < 0.015); the intensity of antihypertensive drug therapy when goal BP was attained was also greater in all conditions linked to slow goal attainment. Cox proportional hazards model that included the above patient characteristics revealed all characteristics slowed attainment of JNC SBP goals (P < 0.03). Thus, patient characteristics influence speed of BP control and practitioners should avoid therapeutic inertia.
Nasser
Samar A
SA
Division of Translational Research and Clinical Epidemiology, Department of Internal Medicine, Wayne State University, 4201 St. Antoine, UHC 4H-33, Detroit, MI 48201, USA. snasser@med.wayne.edu
Lai
Zongshan
Z
O'Connor
Shannon
S
Liu
Xuefeng
X
Flack
John M
JM
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D003971:Diastole; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D053208:Kaplan-Meier Estimate; D008297:Male; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D012307:Risk Factors; D013599:Systole
D000959:Antihypertensive Agents
Arch Intern Med. 2003 Mar 10;163(5):525-41
12622600
J Hum Hypertens. 2006 Mar;20(3):169-75
16397516
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
Am J Manag Care. 2004 Jul;10(7 Pt 2):481-6
15298234
JAMA. 2003 May 21;289(19):2560-72
12748199
Lancet. 2004 Jun 19;363(9426):2049-51
15207957
Hypertension. 2006 Mar;47(3):345-51
16432045
Hypertens Res. 2005 May;28(5):385-407
16156503
Hypertension. 2004 Oct;44(4):429-34
15326088
J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
12461301
Arch Intern Med. 2003 Dec 8-22;163(22):2677-8
14662620
N Engl J Med. 1998 Dec 31;339(27):1957-63
9869666
Am Heart J. 1999 Nov;138(5 Pt 1):856-64
10539816
Circulation. 1995 Nov 1;92(9):2437-45
7586343
Am J Hypertens. 1998 Jun;11(6 Pt 1):744-6
9657637
Am J Hypertens. 1993 Feb;6(2):103-7
8471228
Hypertension. 2004 Oct;44(4):398-404
15326093
Lancet. 2005 Sep 10-16;366(9489):895-906
16154016
N Engl J Med. 2000 Jan 20;342(3):145-53
10639539
J Hypertens. 2004 Apr;22(4):847-57
15126928
Arch Intern Med. 2000 Jun 26;160(12):1842-7
10871979
Ann Epidemiol. 2007 Jan;17(1):27-35
17027287
Arch Intern Med. 1997 Nov 24;157(21):2413-46
9385294
Hypertension. 2001 Oct;38(4):809-14
11641291
Arch Intern Med. 2003 Dec 8-22;163(22):2728-31
14662626
Am J Manag Care. 2002 Sep;8(12 Suppl):S301-7
12240701
J Am Coll Cardiol. 2004 Sep 15;44(6):1175-80
15364316